Health & Science
Health & Science
FDA approves AstraZeneca's Baxfendy, first-in-class drug for tough-to-treat hypertension
The FDA cleared baxdrostat, a first-in-class aldosterone synthase inhibitor, offering a new option for adults whose blood pressure resists standard therapies.